Literature DB >> 3777911

Penetration of amoxicillin and potassium clavulanate into the cerebrospinal fluid of patients with inflamed meninges.

J S Bakken, J N Bruun, P Gaustad, T C Tasker.   

Abstract

A single intravenous dose of 2.0 g of amoxicillin and 0.2 g of potassium clavulanate was given to patients with bacterial meningitis, and the pharmacokinetics of both drugs in the cerebrospinal fluid (CSF) and plasma were evaluated. Twenty-one patients aged 14 to 76 years were studied. Both amoxicillin and potassium clavulanate were detectable in the CSF as early as 1 h and reached peak concentrations by approximately 2 h. The highest mean CSF concentrations were 2.25 micrograms/ml for amoxicillin and 0.25 micrograms/ml for potassium clavulanate and were found in patients with moderately or severely inflamed meninges. The CSF penetration relative to plasma for amoxicillin and potassium clavulanate was 5.8 and 8.4%, respectively. These levels suggest that the amoxicillin-potassium clavulanate combination may be effective for the treatment of bacterial meningitis caused by beta-lactamase-producing pathogens.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3777911      PMCID: PMC180584          DOI: 10.1128/AAC.30.3.481

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

Review 1.  A review of the penetration of antibiotics into CSF and its clinical significance.

Authors:  R Norrby
Journal:  Scand J Infect Dis Suppl       Date:  1978

2.  In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin.

Authors:  P A Hunter; K Coleman; J Fisher; D Taylor
Journal:  J Antimicrob Chemother       Date:  1980-07       Impact factor: 5.790

3.  Effect of food on the bioavailability and tolerance of clavulanic acid/amoxycillin combination.

Authors:  D H Staniforth; R J Lillystone; D Jackson
Journal:  J Antimicrob Chemother       Date:  1982-08       Impact factor: 5.790

Review 4.  Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; A Carmine; R C Heel; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

5.  Concentration of cefuroxime in cerebrospinal fluid in patients with bacterial meningitis.

Authors:  A Netland; C Müller; E Andrew
Journal:  Scand J Infect Dis       Date:  1981

6.  Blood-brain and CSF barriers to penicillin and related organic acids.

Authors:  R A Fishman
Journal:  Arch Neurol       Date:  1966-08

7.  Comparison of netilmicin with gentamicin in the therapy of experimental Escherichia coli meningitis.

Authors:  W M Scheld; R S Brown; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

8.  Amoxicillin-clavulanic acid in the treatment of lower respiratory tract infections caused by beta-lactamase-positive Haemophilus influenzae and Branhamella catarrhalis.

Authors:  R J Wallace; L C Steele; D L Brooks; J I Luman; R W Wilson; J W McLarty
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

9.  Clinical evaluation of piperacillin with observations on penetrability into cerebrospinal fluid.

Authors:  G M Dickinson; D G Droller; R L Greenman; T A Hoffman
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

10.  Effect of meningitis and probenecid on the penetration of vancomycin into cerebrospinal fluid in rabbits.

Authors:  D P Krontz; L J Strausbaugh
Journal:  Antimicrob Agents Chemother       Date:  1980-12       Impact factor: 5.191

View more
  11 in total

Review 1.  New formulations of amoxicillin/clavulanic acid: a pharmacokinetic and pharmacodynamic review.

Authors:  Amparo Sánchez Navarro
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  Evaluation of piperacillin-tazobactam in experimental meningitis caused by a beta-lactamase-producing strain of K1-positive Escherichia coli.

Authors:  W Kern; S L Kennedy; M Sachdeva; E R Sande; D Gunderson; M G Täuber
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

3.  Overton's rule helps to estimate the penetration of anti-infectives into patients' cerebrospinal fluid.

Authors:  Marija Djukic; Martin Munz; Fritz Sörgel; Ulrike Holzgrabe; Helmut Eiffert; Roland Nau
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

4.  Different ratios of the piperacillin-tazobactam combination for treatment of experimental meningitis due to Klebsiella pneumoniae producing the TEM-3 extended-spectrum beta-lactamase.

Authors:  G Leleu; M D Kitzis; J M Vallois; L Gutmann; J M Decazes
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

Review 5.  Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.

Authors:  I D Watson; M J Stewart; D J Platt
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

Review 6.  Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Authors:  Roland Nau; Fritz Sörgel; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 7.  Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

8.  Impact of acid secretion, gastritis, and mucus thickness on gastric transfer of antibiotics in rats.

Authors:  P V Sherwood; J I D Wibawa; J C Atherton; N Jordan; D Jenkins; D A Barrett; P N Shaw; R C Spiller
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

Review 9.  Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.

Authors:  Antonello Di Paolo; Giovanni Gori; Carlo Tascini; Romano Danesi; Mario Del Tacca
Journal:  Clin Pharmacokinet       Date:  2013-07       Impact factor: 6.447

10.  Bactericidal activity against Haemophilus influenzae of cerebrospinal fluid of patients given amoxicillin-clavulanic acid.

Authors:  J M Decazes; A Bure; M Wolff; M D Kitzis; B Pangon; J Modai
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.